Beijing, China

Yang She

This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Agrobiological Sciences. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yang She. Retrieved from https://idiyas.com/inventor/yang-she

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yang She - Innovator in Immunology

Introduction

Yang She is a prominent inventor based in Beijing, China. He has made significant contributions to the field of immunology through his innovative research and development of pharmaceutical compositions.

Latest Patents

Yang She holds a patent for promoting immune responses. His patent, which includes a 1-ADP-heptose conjugate, may also comprise an immunogen or an immune checkpoint inhibitor. This invention is designed to enhance immune responses, showcasing his commitment to advancing medical science.

Career Highlights

Yang She is affiliated with the National Institute of Agrobiological Sciences, where he conducts his research. His work has led to the development of groundbreaking solutions in the field of immunology.

Collaborations

Yang has collaborated with notable colleagues, including Feng Shao and Ping Zhou. These partnerships have further enriched his research and contributed to the success of his projects.

Conclusion

Yang She is a dedicated inventor whose work in immunology has the potential to impact healthcare significantly. His innovative patent and collaborations highlight his role as a key figure in advancing medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…